Autopsy report · NCT01245985

TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors

“slow recruitment (only 8 patients recruited and treated until 12/2012)”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years before it stopped.
• 8 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Heidelberg University

Sponsor type

University, hospital or other

Conditions

Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): Oro-, Hypopharyngeal and Laryngeal Cancer

Interventions

carbon ion boost

Participants

8

Sites

1

Countries

Germany

Trials that died the same way

• Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma
  “slow recruitment of patients” (86% match in meaning)
• Evaluation of the Parietex TM Parastomal No Hole Mesh for Repair of Parastomal Hernias in End-colostomies
  “too slow patiënts recruitment” (83% match in meaning)
• A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma
  “slow patient recruitment” (82% match in meaning)
• A Study Evaluating Bacillus Cereus in the Prevention of Afatinib-associated Diarrhea
  “Participants have better treatment selection, resulting in a slow recruitment.” (81% match in meaning)
• Propofol and Dexmedetomidin vs Midazolam Intraoperative Sedation and POCD
  “Too long recruitment period due to small number of patients” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.